JPRN-UMIN000050578招募中Unknown
Improving the reproducibility of the Action Research Arm Test : a practical decision rule for scoring 2 and 3 points. - ARAT-N Study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria include the following: (1) clear sign of dementia; (2) mental disorder, or aphasia as an obstacle to daily living; (3) excessive pain; (4) the severe end-stage or uncontrolled medical conditions.
研究者
相似试验
尚未招募
不适用
Investigation of respiratory-related tumour motion in liver cancer patients undergoing stereotactic body radiotherapy (SBRT) using audiovisual (AV) biofeedbackLiver cancerACTRN12613000110785niversity of Sydney30
已完成
Unknown
Pilot Study to prove the reproducibility of the intestinal environment of PMAS System through the production of Equol after intake of Soy IsoflavoneKCT0008816HEM Pharma36
已完成
不适用
Study of the influence of reproducibility gripping action and appearance of the electric prosthetic hand upon sense of agencyJPRN-UMIN000024967Okayama University60
已完成
不适用
A pilot study exploring the reproducibility and suitability for multi-center clinical trials of fMRI bold signal during a monetary incentive delay task and arterial spin labeling with and without prior administration of RisperidoneNL-OMON46683Millennium Pharmaceuticals, Inc. A Takeda Oncology Company5
进行中（未招募）
1 期
A pilot study exploring the reproducibility and suitability for multi-center clinical trials of fMRI BOLD signal during a monetary incentive delay task (MID) and arterial spin labeling (ASL) with and without prior administration of risperidone/AMedDRA version: 20.1Level: LLTClassification code 10028049Term: MRISystem Organ Class: 100000004848EUCTR2018-000379-34-NLMillennium Pharmaceuticals, Inc. A Takeda Oncology Company5